Open in interactive viewer → charts, metric popovers & call review

Ramsay Health Care: Transformational Year Sets Stage for Pure-Play Australian Hospital Group

FY26 results show strong margin expansion, capital discipline, and the planned demerger of Ramsay Santé, positioning the company for a focused growth story.
RHC.AX · Earnings Call · 2026-08-26

A Transformational Year

Ramsay Health Care’s full-year results for FY26 underscore a year of deliberate strategic reshaping. The company delivered revenue of $18.6 billion, up 4.2% in constant currency, with underlying EBIT growth of 11.8% and underlying NPAT up 22.9%. The standout was Funding Group performance, which saw ROCE jump 124 basis points to 14.8% and leverage fall to 1.83x, well below its 2.5x target. As CFO Anthony Neilson put it, "We strengthened capital discipline, focusing growth in development CapEx on Australia and procedural capacity, reflected in group ROIC increasing by 30 basis points and Funding Group ROIC plus 60 basis points to 6.3%." “...we've made good progress delivering against our 3 key priorities.” — Natalie Davis, Managing Director and Group CEO · 2026-08-26 The most significant strategic move is the planned separation of Ramsay Santé, which remains on track for a shareholder vote on 24 November 2026. This demerger will simplify Ramsay into a pure-play Australian hospital operator, relieving it of the challenging French funding environment and allowing investors to directly hold a stake in the European business. The company has emphasized that Ramsay Santé already operates independently with its own financing, minimizing separation complexity.

Australia: The Engine of Growth

Australia delivered an 8% revenue increase, with underlying EBIT up 11.2% and a 30 basis point margin improvement to 9.4%. Growth was driven by higher acuity, improved theater utilization (now 70%, up from 69%), and strong private admissions growth. A key driver is the push for revenue indexation that keeps pace with costs. In Q&A, Natalie Davis reiterated: “We will continue to seek revenue indexation that is in line with our cost indexation.” — Natalie Davis, Managing Director and Group CEO · 2026-08-26 The company has already signed agreements covering about 48% of its private health insurer revenue that incorporate formula-linked indexation, reducing the annual negotiation friction. Another notable theme is the innovative approach to mental health funding. Ramsay is working with insurers to move beyond the traditional length-of-stay model toward community-based care, which improves patient outcomes and reduces readmissions. As Natalie described: “We know the community is changing... we've been working with a number of our private health insurer partners to effectively change the way that we're funded.” — Natalie Davis, Managing Director and Group CEO · 2026-08-26 The upcoming acquisition of Nat Cap (National Capital Private Hospital) next week is expected to be EPS-accretive in its first year, and the company is planning to expand its theater and cath lab capacity given the hospital's already high utilization. This fits the broader strategy of adding capacity only where utilization exceeds 80-85%, as seen in top sites like Hollywood and St. George.

Looking Ahead: Separation and Focus

Looking into FY27, Ramsay expects continued EBIT growth in Australia and the UK, with modest margin expansion despite a $10-15 million investment in IT and technology. The company also reaffirmed its commitment to capital discipline, with group CapEx guidance of $480-520 million for the Funding Group, consistent with FY26 spend. The separation of Ramsay Santé will be a major catalyst, and the company will host an Investor Day on 30 November to detail its post-demerger strategy. While global markets remain fixated on AI and tariffs, Ramsay's story is resolutely healthcare-specific, and its own keyword trajectory highlights the transformation themes that dominate the call. The recent reporters list shows other healthcare names like Agilent (A) and Ambu (AMBU-B.CO) also touching on operational excellence and cash generation, but none with the scale or strategic clarity of Ramsay's pivot.

We're preparing for the proposed separation of Ramsay Santé in December, subject to Ramsay shareholder vote on the 24th of November. The group executive will host an Investor Day on the 30th of November to share our progress and plans as we continue to evolve Ramsay for the future.

All told, Ramsay Health Care has laid out a clear, executable plan to enhance shareholder value through focused portfolio management, operational efficiency, and disciplined capital allocation. The demerger, if approved, will mark a new era for the company, and today's results provide strong evidence that the transformation is already yielding tangible financial benefits.